NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class: Equity / Common Stock
Shares outstanding: 99,605,545
Number of holders: 326
Total 13F shares, excl. options: 89,723,577
Shares change: +1,404,667
Total reported value, excl. options: $8,083,967,833
Value change: +$131,837,632
Put/Call ratio: 93.6%
Number of buys: 178
Number of sells: -134
Price: $90.11

Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2019

387 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2019.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 326 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 89,723,577 shares of 99,605,545 outstanding shares and own 90.1% of the company stock.
Largest 10 shareholders include FMR LLC (8,628,780 shares), JANUS HENDERSON GROUP PLC (8,503,536 shares), VANGUARD GROUP INC (8,216,386 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,730,360 shares), BlackRock Inc. (5,936,118 shares), Capital International Investors (5,830,476 shares), PERCEPTIVE ADVISORS LLC (4,059,900 shares), Bellevue Group AG (3,298,474 shares), FRANKLIN RESOURCES INC (1,860,519 shares), and STATE STREET CORP (1,827,556 shares).
This table shows the top 326 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.